Robertson Stephens Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.5M Sell
14,683
-61
-0.4% -$61.8K 0.38% 49
2025
Q4
$15.8M Buy
14,744
+8,053
+120% +$7.7M 0.41% 45
2025
Q3
$5.11M Sell
6,691
-562
-8% -$418K 0.15% 100
2025
Q2
$5.65M Buy
7,253
+1,278
+21% +$993K 0.18% 94
2025
Q1
$4.93M Buy
5,975
+484
+9% +$403K 0.17% 106
2024
Q4
$4.24M Sell
5,491
-80
-1% -$66.2K 0.15% 125
2024
Q3
$4.94M Buy
5,571
+69
+1% +$62K 0.18% 114
2024
Q2
$4.98M Buy
5,502
+491
+10% +$393K 0.25% 74
2024
Q1
$3.9M Buy
5,011
+866
+21% +$616K 0.21% 90
2023
Q4
$2.42M Buy
4,145
+971
+31% +$567K 0.15% 125
2023
Q3
$1.7M Buy
3,174
+594
+23% +$306K 0.12% 156
2023
Q2
$1.21M Sell
2,580
-327
-11% -$137K 0.09% 173
2023
Q1
$998K Buy
2,907
+380
+15% +$128K 0.08% 198
2022
Q4
$924K Sell
2,527
-1,128
-31% -$400K 0.09% 184
2022
Q3
$1.18M Sell
3,655
-400
-10% -$127K 0.12% 136
2022
Q2
$1.31M Sell
4,055
-2,067
-34% -$620K 0.12% 137
2022
Q1
$1.75M Buy
6,122
+1,741
+40% +$448K 0.15% 124
2021
Q4
$1.21M Buy
4,381
+3,445
+368% +$873K 0.1% 164
2021
Q3
$216K Buy
+936
New +$231K 0.02% 296

Other funds holding LLY

Robertson Stephens Wealth Management's LLY Position: Q1 2026 in Review

Robertson Stephens Wealth Management reduced its Eli Lilly (LLY) stake by 0.41% in Q1 2026, selling an estimated $61.8K and leaving 14,683 shares worth $13.5M. The position accounts for 0.38% of the portfolio, ranked #49.

Robertson Stephens Wealth Management first reported a position in LLY in Q3 2021 and has held it in 19 quarters since. The position peaked at $15.8M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Robertson Stephens Wealth Management held 14,683 shares of Eli Lilly worth $13.5M as of Q1 2026.
  • Robertson Stephens Wealth Management sold 61 Eli Lilly shares in Q1 2026, an estimated $61.8K.
  • Eli Lilly made up 0.38% of Robertson Stephens Wealth Management's portfolio in Q1 2026, its #49 holding.
  • Robertson Stephens Wealth Management first reported a position in Eli Lilly in Q3 2021 and has held it in 19 quarters since.
  • Robertson Stephens Wealth Management's Eli Lilly position peaked at $15.8M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Robertson Stephens Wealth Management's 13F filing for Q1 2026, filed 28 Apr 2026.